
Keywords: گلوکوکورتیکوئیدها موضعی; AD, atopic dermatitis; HC, hydrocortisone; HT, hydroxytyrosol; CSNPs, chitosan nanoparticles; DPK, dermal pharmacokineticsPolymeric nanoparticles; Skin disease; Chitosan; Topical glucocorticoids; Antimicrobial activity; Dermal pharmacokinetics; Safety